Small-molecule conversion of toxic oligomers to nontoxic β-sheet-rich amyloid fibrils
- Nat Chem Biol. 2011 Nov 20;8(1):93-101. doi: 10.1038/nchembio.719.
- 1. Neuroproteomics, Max Delbrueck Center for Molecular Medicine, Berlin, Germany.
Several lines of evidence indicate that prefibrillar assemblies of Amyloid-β (Aβ) polypeptides, such as soluble oligomers or protofibrils, rather than mature, end-stage amyloid fibrils cause neuronal dysfunction and memory impairment in Alzheimer's disease. These findings suggest that reducing the prevalence of transient intermediates by small molecule-mediated stimulation of amyloid polymerization might decrease toxicity. Here we demonstrate the acceleration of Aβ fibrillogenesis through the action of the orcein-related small molecule O4, which directly binds to hydrophobic amino acid residues in Aβ peptides and stabilizes the self-assembly of seeding-competent, β-sheet-rich protofibrils and fibrils. Notably, the O4-mediated acceleration of amyloid fibril formation efficiently decreases the concentration of small, toxic Aβ oligomers in complex, heterogeneous aggregation reactions. In addition, O4 treatment suppresses inhibition of long-term potentiation by Aβ oligomers in hippocampal brain slices. These results support the hypothesis that small, diffusible prefibrillar amyloid species rather than mature fibrillar aggregates are toxic for mammalian cells.
-
Cat. No.Product NameDescriptionTargetResearch Area
-
Research Areas: Neurological Disease